Borean Pharma Appoints Dr. Johanna Holldack as Chief Operating Officer
Appointment reflects Borean Pharma`s progress towards the execution of its business strategy of partnering and licensing
10-Oct-2003 -
Borean Pharma today announced the appointment of Johanna Holldack, M.D., as Chief Operating Officer. With more than 13 years of experience in the pharmaceutical and biotech industries, Dr. Holldack has been responsible for the development and approval of products both in the U.S. and Europe. In ...
Chiron
diseases
Germany
+7